US 6,410,033 B1 · Recombinant infectious bovine rhinotracheitis virus

Abstract

The present invention provides a recombinant infectious bovine rhinotracheitis designated S-IBR-052 (ATCC Accession No. VR 2443). The present invention also provides a vaccine which comprises an effective immunizing amount of the recombinant infectious bovine rhinotracheitis virus designated S-IBR-052 and a suitable carrier. The present invention provides homology vectors, methods of immunization and a method of distinguishing an animal vaccinated with the vaccines of the present invention from an animal infected with a naturally-occurring infectious bovine rhinotracheitis virus.

Claims30

Dependent claims

A recombinant infectious bovine rhinotracheitis virus comprising a foreign DNA sequence inserted into an infectious bovine rhinotracheitis viral genome, wherein the foreign DNA sequence is inserted within the BamHI C fragment of the infectious bovine rhinotracheitis viral genome and is capable of being expressed in an infectious bovine rhinotracheitis virus infected host cell.

Dependencies are inferred from the claim text.

Facts

Application

08/379,647Filed 5 Aug 1996 · continuation in part

Priority

27 Jul 1987

Granted

25 Jun 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 39/265
Herpetoviridae, e.g. herpes simplex virus: infectious rhinotracheitis virus
A61K 39/12
Medicinal preparations containing antigens or antibodies: viral antigens
C12N 7/00
Viruses
C12N 15/86
For animal cells: viral vectors

Family

Application07/078,519Parent of this continuation · filed 27 Jul 1987

Application07/649,380Parent of this continuation · filed 31 Jan 1991

Application08/037,707Parent of this continuation · filed 25 Mar 1993

Application08/191,866Parent of this continuation-in-part · filed 4 Feb 1994

Application08/334,428Parent of this continuation-in-part · filed 4 Nov 1994

US 5,834,305 AParent of this continuation-in-part

US 5,783,195 AParent of this continuation-in-part

Application08/191,866Parent of this continuation

US 6,410,033 B1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

08/379,647Filed 5 Aug 1996 · continuation in part

Priority

27 Jul 1987

Granted

25 Jun 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 39/265
Herpetoviridae, e.g. herpes simplex virus: infectious rhinotracheitis virus
A61K 39/12
Medicinal preparations containing antigens or antibodies: viral antigens
C12N 7/00
Viruses
C12N 15/86
For animal cells: viral vectors

Family

Application07/078,519Parent of this continuation · filed 27 Jul 1987

Application07/649,380Parent of this continuation · filed 31 Jan 1991

Application08/037,707Parent of this continuation · filed 25 Mar 1993

Application08/191,866Parent of this continuation-in-part · filed 4 Feb 1994

Application08/334,428Parent of this continuation-in-part · filed 4 Nov 1994

US 5,834,305 AParent of this continuation-in-part

US 5,783,195 AParent of this continuation-in-part

Application08/191,866Parent of this continuation

US 6,410,033 B1This patent

From the US filing history. Foreign family members aren’t listed.

Recombinant infectious bovine rhinotracheitis virus

Life of this patent

Abstract

Claims30

Recombinant infectious bovine rhinotracheitis virus

Life of this patent

Abstract

Claims30